
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 878 | 848 | 1006 | 1261 | 2014 | - |
Fund Return | -12.17% | -15.19% | 0.55% | 8.04% | 15.03% | - |
Place in category | 2199 | 2113 | 1101 | 372 | 20 | - |
% in Category | 72 | 70 | 42 | 18 | 2 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
G Fund Total Return All Cap Europei | 648.11M | 5.58 | 7.59 | 5.73 | ||
G Fund Total Return All Cap Europee | 648.11M | 5.40 | 7.09 | 5.23 | ||
LU1897556350 | 554.65M | -11.92 | 8.92 | - | ||
G Fund Avenir Euro NC | 112.08M | -3.05 | -13.34 | 7.73 | ||
G Fund Avenir Euro IC | 112.08M | -2.17 | -12.70 | 8.49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux N | 16.37B | -0.26 | 8.12 | - | ||
Cap Group New Perspective lux C EUR | 16.37B | 0.43 | 10.53 | - | ||
Cap Group NewPerspective lux ZL EUR | 16.37B | 0.27 | 9.90 | 10.12 | ||
Cap Group NewPerspective lux A7 EUR | 16.37B | 0.26 | 10.04 | - | ||
Capital Group New Perspective Funde | 16.37B | 0.27 | 9.94 | 10.15 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Baker Hughes | US05722G1004 | 6.27 | 36.49 | +0.66% | |
Motorola | US6200763075 | 5.58 | 406.50 | -0.94% | |
Cyberark Software | IL0011334468 | 5.43 | 359.51 | -1.36% | |
Microsoft | US5949181045 | 5.40 | 438.73 | +0.13% | |
Boston Scientific | US1011371077 | 5.27 | 102.86 | -0.42% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Neutral |
Technical Indicators | Strong Buy | Strong Sell | Strong Sell |
Summary | Buy | Neutral | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review